Clinical Trials Directory

Trials / Completed

CompletedNCT01221805

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Status
Completed
Phase
Study type
Observational
Enrollment
2,040 (actual)
Sponsor
Diagnostica Stago · Industry
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.

Detailed description

The study population will be selected from prospective, consecutive ambulatory outpatients suspected of having venous thromboembolism. These patients will first be evaluated using the Wells score: * patients with low or moderate pretest probability will be considered for D-dimer testing, those with D-dimer positive will be considered for an imaging procedure, * patients with high pretest probability will be considered for an imaging procedure. Patients with "low or moderate" pretest probability and a negative D-Dimer result will be followed for 3 months to evaluate potential development of deep venous thrombosis and/or pulmonary embolism. These patients will be contacted by phone 3 month after their first visit.

Conditions

Timeline

Start date
2011-11-01
Primary completion
2016-03-01
Completion
2016-04-01
First posted
2010-10-15
Last updated
2016-08-05

Locations

18 sites across 5 countries: United States, Canada, France, Italy, Spain

Source: ClinicalTrials.gov record NCT01221805. Inclusion in this directory is not an endorsement.

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism (NCT01221805) · Clinical Trials Directory